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Summary 
 
     Yearling steers were randomized to treat-
ment and vaccinated with 5-way modified live 
viral vaccine and Mannheimia haemolytica 
bacterin/toxoid by using either needle-free or 
standard needle injection. Blood samples were 
collected from all animals at the time of vac-
cination and 21 days later, and the serum was 
analyzed for antibody titers to infectious bo-
vine rhinotracheitis (IBR) virus and M. 
haemolytica leukotoxoid. Serological re-
sponses to the IBR viral fraction of the 5-way 
viral vaccine were significantly greater on day 
21 after administration with the needle-free 
injection system.  Serological responses to the 
M. haemolytica leukotoxoid tended to be 
greater on day 21 after administration with the 
needle-free injection system. 
 
Introduction 
 
     Beef quality-assurance guidelines recom-
mend that the most tissue-friendly route of 
administration of injectable products be used 
whenever possible.  One new technology that 
offers potential to meet that objective is the 
use of a needle-free injection device (Felton 
250 PulseTM Needle-Free Injector), a pneu-
matically powered device (Figure 1) that uses 
air pressure to administer the vaccine through 
the skin and into the underlying subcutaneous 
or muscle tissues (Figure 2).  The question 
arises:  Do the cattle respond to the vaccines 
the same way as when vaccinated with con-
ventional needle and syringe?  The purpose of 
this study was to compare efficacy, as meas-
ured by seroconversion, when a vaccine and a 
bacterin/leukotoxoid were injected with either 
needle-free or traditional needle injection 
methods.      
 
Procedures 
 
          One hundred eleven uniform yearling 
steers (806 lb) from a single ranch were used 
for the study.  Animals were individually 
identified, blood samples were collected, and 
serum was harvested from blood and frozen.  
All animals were vaccinated with a 5-way 
modified live respiratory viral vaccine (Bovi-
Shield® Gold 5) and a M. haemolytica bac-
terin/leukotoxoid (One Shot®). Needle-free 
and standard needle routes of administration 
were randomized between pairs of animals as 
they entered the squeeze chute.  Those ani-
mals selected to receive the viral vaccine by 
needle-free injection received the bacterin/ 
leukotoxoid by standard needle injection.  The 
other animal of each pair received the viral 
vaccine by needle injection and the bac-
terin/leukotoxoid by needle-free injection.  
The Felton needle-free injector was set to 85 
psi to ensure intramuscular injection of the 
viral vaccine, and it was set at 75 psi to ensure 
subcutaneous injection of the bac-
terin/leukotoxoid.  On day 21, blood samples 
were collected from all steers, and the serum 
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was harvested.  All serum samples were for-
warded to the Kansas State University Veteri-
nary Diagnostic Laboratory and were analyzed 
for antibody titers to IBR virus and M. haemo-
lytica leukotoxoid.  Antibody titers from day 0 
and day 21 were compared and statistically 
analyzed (Table 1). 
 
Results and Discussion 
 
     Serological responses to the IBR fraction 
of the 5-way viral vaccine were significantly 
greater (P=0.0014) on day 21 after administra-
tion with the needle-free injection system than 
with the standard needle route of administra-
tion.  Serological responses to the M. haemo-
lytica bacterin/toxoid also tended to be greater 
(P=0.06) on day 21 after administration with 
the needle-free injection system.  This study 
indicated that use of a needle-free injection 
system resulted in serological responses at 
least as good as traditional needle injection 
methods.   
    
 
 
Table 1. Serological Responses to IBR Vaccine and Mannheimia haemolytica Bac-
terin/Toxoid 
Treatment Day 0 Titer SEM Day 21 Titer SEM 
IBR     
          Needle  2.0 0.67 42b 5.9 
          Needle-free  2.5 0.47 70a 10.8 
               P value 0.95  0.0014  
     
Mannheimia haemolytica     
          Needle  0.240 0.009 0.299 0.011 
          Needle-free  0.259 0.011 0.326 0.011 
               P value 0.20  0.06  
abValues differ, P≤0.05. 
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Figure 1.  Felton Pulse 250 Needle-free Injection System. 
 
 
 
 
Figure 2.  Felton Needle-free Injector. 
 
 
